You are here
AFFINITY THERAPEUTICS, LLC
UEI: MVSNZ6XDQAE9
# of Employees: 5
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Localized Statin Delivery for Prevention of Primary AV Fistula Failure
Amount: $225,000.00Abstract Summary Arteriovenous fistulas AVFs are the preferred vascular access mode for hemodialysis patients but of AVFs fail to mature and only of mature AVFs are patent after year V ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Affinity-based delivery of Sirolimus for prevention of AV graft failure
Amount: $376,752.00DESCRIPTION provided by applicant There are greater than million patients that suffer end stage renal disease requiring hemodialysis Long term vascular access is vital for these patients to un ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
SBIR Phase I: Feasibility of a Vaginal Ring for Delivery of Protein Drugs in HIV Prevention
Amount: $149,999.00This Small Business Innovation Research (SBIR) Phase I project concerns a major health concern both here in the US and abroad. Currently, no long-term vaginal delivery device is available for the deli ...
SBIRPhase I2013National Science Foundation -
Cyclodextrin-based Microparticle Polymer Formulations for the Slow and Sustained
Amount: $399,998.00DESCRIPTION (provided by applicant): One of the leading causes of failure for medical devices is infection. In particular synthetic mesh infections after ventral hernia repair are a common surgical pr ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health